Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States. (1st July 2022)
- Record Type:
- Journal Article
- Title:
- Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States. (1st July 2022)
- Main Title:
- Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States
- Authors:
- Ignacio, Rachel A. Bender
Shapiro, Adrienne E.
Nance, Robin M.
Whitney, Bridget M.
Delaney, Joseph A.C.
Bamford, Laura
Wooten, Darcy
Karris, Maile Y.
Mathews, William C.
Kim, Hyang Nina
Keruly, Jeanne
Burkholder, Greer
Napravnik, Sonia
Mayer, Kenneth H.
Jacobson, Jeffrey
Saag, Michael
Moore, Richard D.
Eron, Joseph J.
Willig, Amanda L.
Christopoulos, Katerina A.
Martin, Jeffrey
Hunt, Peter W.
Crane, Heidi M.
Kitahata, Mari M.
Cachay, Edward R. - Abstract:
- Abstract : Objectives: To define the incidence of clinically detected coronavirus disease 2019 (COVID-19) in people with HIV (PWH) in the United States and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19. Design: Observational study within the CFAR Network of Integrated Clinical Systems cohort in seven cities during 2020. Methods: We calculated cumulative incidence rates of COVID-19 diagnosis among PWH in routine care by key characteristics including race/ethnicity, current and lowest CD4 + cell count, and geographic area. We evaluated risk factors for COVID-19 among PWH using relative risk regression models adjusted with disease risk scores. Results: Among 16 056 PWH in care, of whom 44.5% were black, 12.5% were Hispanic, with a median age of 52 years (IQR 40–59), 18% had a current CD4 + cell count less than 350 cells/μl, including 7% less than 200; 95.5% were on antiretroviral therapy (ART), and 85.6% were virologically suppressed. Overall in 2020, 649 PWH were diagnosed with COVID-19 for a rate of 4.94 cases per 100 person-years. The cumulative incidence of COVID-19 was 2.4-fold and 1.7-fold higher in Hispanic and black PWH respectively, than non-Hispanic white PWH. In adjusted analyses, factors associated with COVID-19 included female sex, Hispanic or black identity, lowest historical CD4 + cell count less than 350 cells/μl (proxy for CD4 + nadir), current low CD4 + : CD8 + ratio, diabetes, and obesity.Abstract : Objectives: To define the incidence of clinically detected coronavirus disease 2019 (COVID-19) in people with HIV (PWH) in the United States and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk of COVID-19. Design: Observational study within the CFAR Network of Integrated Clinical Systems cohort in seven cities during 2020. Methods: We calculated cumulative incidence rates of COVID-19 diagnosis among PWH in routine care by key characteristics including race/ethnicity, current and lowest CD4 + cell count, and geographic area. We evaluated risk factors for COVID-19 among PWH using relative risk regression models adjusted with disease risk scores. Results: Among 16 056 PWH in care, of whom 44.5% were black, 12.5% were Hispanic, with a median age of 52 years (IQR 40–59), 18% had a current CD4 + cell count less than 350 cells/μl, including 7% less than 200; 95.5% were on antiretroviral therapy (ART), and 85.6% were virologically suppressed. Overall in 2020, 649 PWH were diagnosed with COVID-19 for a rate of 4.94 cases per 100 person-years. The cumulative incidence of COVID-19 was 2.4-fold and 1.7-fold higher in Hispanic and black PWH respectively, than non-Hispanic white PWH. In adjusted analyses, factors associated with COVID-19 included female sex, Hispanic or black identity, lowest historical CD4 + cell count less than 350 cells/μl (proxy for CD4 + nadir), current low CD4 + : CD8 + ratio, diabetes, and obesity. Conclusion: Our results suggest that the presence of structural racial inequities above and beyond medical comorbidities increased the risk of COVID-19 among PWH. PWH with immune exhaustion as evidenced by lowest historical CD4 + cell count or current low CD4 + : CD8 + ratio had greater risk of COVID-19. … (more)
- Is Part Of:
- AIDS. Volume 36:Number 8(2022)
- Journal:
- AIDS
- Issue:
- Volume 36:Number 8(2022)
- Issue Display:
- Volume 36, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 36
- Issue:
- 8
- Issue Sort Value:
- 2022-0036-0008-0000
- Page Start:
- 1095
- Page End:
- 1103
- Publication Date:
- 2022-07-01
- Subjects:
- coronavirus disease 2019 acquisition -- HIV -- immune exhaustion -- racial disparities
AIDS (Disease) -- Periodicals
Acquired Immunodeficiency Syndrome
AIDS (Disease)
Periodicals
Periodicals
616.9792005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002030-000000000-00000 ↗
http://journals.lww.com/aidsonline/pages/default.aspx?desktopMode=true ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/QAD.0000000000003223 ↗
- Languages:
- English
- ISSNs:
- 0269-9370
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0773.083000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22584.xml